CREFX
Price
$17.56
Change
+$0.09 (+0.52%)
Updated
Aug 15 closing price
Net Assets
8.05B
RRRSX
Price
$21.20
Change
+$0.12 (+0.57%)
Updated
Aug 15 closing price
Net Assets
1.01B
Interact to see
Advertisement

CREFX vs RRRSX

Header iconCREFX vs RRRSX Comparison
Open Charts CREFX vs RRRSXBanner chart's image
Cohen & Steers Real Estate Securities F
Price$17.56
Change+$0.09 (+0.52%)
VolumeN/A
Net Assets8.05B
DWS RREEF Real Estate Securities R
Price$21.20
Change+$0.12 (+0.57%)
VolumeN/A
Net Assets1.01B
CREFX vs RRRSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CREFX vs. RRRSX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CREFX is a Buy and RRRSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CREFX has more cash in the bank: 8.05B vs. RRRSX (1.01B). CREFX pays higher dividends than RRRSX: CREFX (2.61) vs RRRSX (2.20). CREFX was incepted earlier than RRRSX: CREFX (8 years) vs RRRSX (22 years). RRRSX (1.30) is less costly to investors than CREFX (0.75). RRRSX is a more actively managed with annual turnover of: 106.00 vs. CREFX (35.00). CREFX (0) and RRRSX (0) have matching initial minimum investment requirements. CREFX annual gain was more profitable for investors over the last year : 0.70 vs. RRRSX (-2.94). CREFX return over 5 years is better than : 33.69 vs. RRRSX (17.01).
CREFXRRRSXCREFX / RRRSX
Total Expense Ratio0.751.3058%
Annual Report Gross Expense Ratio0.751.3058%
Fund Existence8 years22 years-
Gain YTD3.291-1.580-208%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets8.05B1.01B800%
Annual Yield % from dividends2.612.20119%
Returns for 1 year0.70-2.94-24%
Returns for 3 years0.87-3.33-26%
Returns for 5 years33.6917.01198%
Returns for 10 yearsN/A8.57-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLUE4.580.23
+5.29%
Monte Rosa Therapeutics
RGC13.120.42
+3.31%
Regencell Bioscience Holdings Limited
MCD308.93-0.02
-0.01%
McDonald's Corp
LMB113.90-1.23
-1.07%
Limbach Holdings
TACT4.06-0.14
-3.33%
TransAct Technologies